Actelion

Actelion’s Hiring of Goldman May Lead to Sale, Vontobel Says
Bloomberg
Fri, 03/18/11 - 09:02 am
Actelion
M&A
Actelion On The Defensive: Corporate Governance White Paper
InVivo
Thu, 03/10/11 - 12:02 pm
Actelion
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
M&A
biotech
Biogen Idec
Human Genome
Seattle Genetics
GSK
Dendreon
Actelion
Biomarin
Exelixis
Vertex Pharmaceuticals
Celgene
Alexion
Shire
InterMune
Lexicon Pharmaceuticals
Savient
Merck KGaA
Jury Nails J&J With $482 Million Patent Infringement Verdict: Biotech's Latest Tribulations
Seeking Alpha
Mon, 02/7/11 - 08:01 am
JNJ
GSK
Pfizer
Teva Pharmaceuticals
Actelion
Actelion Boss Won’t Give Up Without a Fight
WSJ Online
Fri, 02/4/11 - 11:07 am
Actelion
Actelion Enters Evel Knievel Territory
WSJ Online
Mon, 01/31/11 - 11:51 am
Actelion
Tracleer
PAH
How GlaxoSmithKline Lost $635M in Bad Bets on Sleeping Pills
BNET Pharma
Fri, 01/28/11 - 12:14 pm
GSK
insomnia
Actelion
almorexant
Lunesta
Sunovion
Amgen, Actelion Talk but No Offer Made
TheStreet.com
Mon, 12/13/10 - 10:13 am
Amgen
Actelion
M&A
Actelion Wants to Remain Independent, CEO Clozel Says
Bloomberg
Sat, 12/11/10 - 10:49 am
M&A
Amgen
Actelion
Actelion Takeover: Constant Speculation, Doubts Linger
Seeking Alpha
Mon, 11/29/10 - 09:04 am
M&A
Abbott Laboratories
Actelion
GSK
JNJ
Roche
Amgen
Bristol-Myers Squibb
Amgen Holder Invesco Says Potential Actelion Deal Not `Hugely Compelling'
Bloomberg
Tue, 11/23/10 - 10:49 am
Amgen
M&A
Actelion
Actelion: Genzyme-Sanofi Redux?
WSJ Online
Mon, 11/22/10 - 10:32 am
Genzyme
Actelion
Sanofi
M&A
Bayer
Amgen
AstraZeneca
Actelion, Eyed by Amgen, May Fetch $9.8 Billion in Takeover, Analysts Say
Bloomberg
Thu, 11/18/10 - 07:58 am
Actelion
Amgen
M&A
Actelion shares surge (again) as M&A buzz hits fever pitch
Fierce Biotech
Wed, 11/17/10 - 11:46 am
Actelion
M&A
Amgen
Actelion Sets $827 Million Share Repurchase as Takeover Speculation Swirls
Bloomberg
Thu, 10/21/10 - 10:48 am
Actelion
share repurchase
M&A
earnings
Novartis Halts Development of Two Drugs: Biotech's Latest Tribulations
Seeking Alpha
Mon, 10/11/10 - 11:20 am
Novartis
Actelion
AstraZeneca
Human Genome
JNJ
ONYX Pharmaceuticals
Pfizer
Rosetta Genomics
Targacept
Mycograb
albinterferon alfa-2b
Actelion Surges on Report It May Be Weighing Selling Itself
Bloomberg
Fri, 10/8/10 - 08:09 am
Actelion
M&A
GSK
Roche
Amgen
Bristol-Myers Squibb
FDA Slams Actelion Amid BMS Buyout Rumors
Motley Fool
Thu, 10/7/10 - 06:03 pm
Bristol-Myers Squibb
FDA
Actelion
M&A
Tracleer
Ventavis
Actelion Pharma Failed To Report 3,500 Deaths
Pharmalot
Thu, 10/7/10 - 11:49 am
Actelion
FDA
adverse events
Tracleer
Ventavis
FDA Warns Actelion Unit On Post-Marketing Drug Report Failures
WSJ Online
Tue, 10/5/10 - 11:12 am
FDA
Actelion
post-marketing data
Tracleer
Ventavis
PAH

Pages